News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

New Optomechanical Fluidic Sensor Analyzes Cell Mechanics in the Human Body and May Provide Clinical Laboratories with Useful New Diagnostic Tool

Researchers believe newly developed optomechanical technology might eventually be used by medical laboratories

Pathologists and medical laboratory scientists have long been aware of the parallel between cancer and the mechanical properties located in cells. However, a diagnostic tool to assess these properties has until now been unavailable. This may soon change.

A team at the University of Illinois at Urbana-Champaign (UIUC) recently created a technique involving “OptoMechanoFluidics” that might increase understanding of how diseases reshape the mechanical attributes of cells in the human body. The researchers’ innovative opto-mechano-fluidic approach could provide a new way to study how human cells congregate in tissue and bones by examining high-speed photonic sensing of free-flowing particles in the body at rates potentially reaching 10,000 particles per second.

The researchers published their findings in Optica, the online journal of the Optical Society (OSA). Gaurav Bahl, PhD, Assistant Professor, Mechanical Science and Engineering at UIUC, was one of the authors of the study. (See Optica, “High-throughput sensing of freely flowing particles with optomechanofluidics,” Vol. 3, Issue 6, pp. 585-591, 2016.) (more…)

Super-Fast Microscope Captures Circulating Tumor Cells with High Sensitivity and Resolution in Real Time

Pathology groups and clinical labs could use the world’s fastest camera to diagnose cancer at earlier stages

There’s a new optical microscope that can detect rogue cancer cells. It was developed by engineers at the University of California Los Angeles (UCLA). The achievement could create new diagnostic capabilities for pathology and clinical laboratory medicine.

New Instrument Detects Circulating Tumor Cells

The target for this new high-speed microscope are Circulating cancer tumor cells (CTC). CTCs are the precursors to metastasis and metastatic cancer accounts for about 90% of cancer mortalities. However, CTCs are difficult to find and identify. Among a billion healthy cells, only a minute number of CTCs exist. (more…)

Sony Makes Sizable Investments in Medical Devices and Clinical Pathology Laboratory Testing

Consumer electronics giant wants to create patient-friendly medical devices and diagnostic kits that will be used in point-of-care settings

Sony is laying groundwork for a major expansion into the world of medical devices, with a particular interest in medical laboratory testing and diagnostic test kits. Experts point to Sony’s new strategy as a sign that prospects in diagnostic testing remain incredibly strong.

Citing unnamed sources, the Israeli business daily Globes printed a story reporting that consumer electronics giant Sony Corporation (NYSE:SNE) is actively seeking to invest hundreds of millions of dollars in Israeli medical technologies.

Confluence of Electronics and Medical Devices Heats Up Sector

This is a major strategy change for Sony and company officials state that Sony will rely less on consumer electronics as it shifts its focus to other sectors, particularly medical devices and clinical diagnostics, in an effort to revive earnings. This was reported in a story reported by Business Week.
(more…)

;